Our approach is centered on a personalized, multi-modal strategy that factors in your medical history and biochemical profile derived from comprehensive laboratory assessments. Your individualized care plan will feature specific nutraceuticals and, where necessary, bio-identical hormones. These interventions are designed to optimize your cellular health and reinvigorate the functionality of your genes.
To halt the progression of macular degeneration most effectively, it's crucial to initiate treatment as soon as possible, before macula damage becomes permanent. Once the damage is irreversible, our options are limited to stabilizing the condition. However, early intervention can potentially reverse vision loss.
Our approach includes a targeted mix of hormonal treatments, carefully chosen nutraceuticals, and personalized nutritional guidance derived from individual lab tests. We aim to reactivate genes that have become inactive as a result of aging. Our studies indicate that this method can not only stabilize but potentially enhance vision in nearly half of the participants suffering from macular degeneration. Additionally, it could decrease the frequency of eye injections and reduce the chances of the condition worsening from the dry type to the more severe wet type.
We highly advocate for patients to undertake this program, which is grounded in scientific research, as soon as possible. Early participation can significantly diminish the likelihood of the disease advancing to an irreversible stage.
Our approach is centered on a personalized, multi-modal strategy that factors in your medical history and biochemical profile derived from comprehensive laboratory assessments. Your individualized care plan will feature specific nutraceuticals and, where necessary, bio-identical hormones. These interventions are designed to optimize your cellular health and reinvigorate the functionality of your genes.
To halt the progression of macular degeneration most effectively, it's crucial to initiate treatment as soon as possible, before macula damage becomes permanent. Once the damage is irreversible, our options are limited to stabilizing the condition. However, early intervention can potentially reverse vision loss.
Difficulty seeing in dim light.
Slowly progressive blurred vision not improved with glasses.
Distorted Vision: Straight lines might appear wavy or curved, which is a sign of wet macular degeneration.
Spots: There may be dark blind spots in the center of vision which may be transitory.
Difficulty seeing in dim light..
Slowly progressive blurred vision not improved with glasses.
Distorted Vision: Straight lines might appear wavy or curved, which is a sign of wet macular degeneration.
Spots: There may be dark blind spots in the center of vision which may be transitory
The HOMING Method guides the personalized care plan for Age-related Macular Degeneration (AMD).
HOMING is an acronym for Hormones, Oxidation, Methylation, Inflammation, Nutrition and Genetics. The goal is to improve cell biochemistry either directly or by epigenetic mechanisms, (reawakening dormant genes that down regulate with aging)
Literature Citation demonstrating stability and improvement of dry and wet AMD
In 2020, we conducted a study with 365 dry or wet AMD patients. We found that stability or improvement was possible for dry or wet AMD.
48% of dry AMD improved.
60% of wet AMD improved.
In 2020, we conducted a study with 365 dry or wet AMD patients. We found that stability or improvement was possible for dry or wet AMD.
It won the Advancements in Health Care Award.
Had it not been for our success in many patients we may never have pursued macular degeneration.
We discuss the discovery process in our presentations.
The HOMING method has been a success in many clinical conditions indicating that addresses root causes of disease.
It won the Advancements in Health Care Award.
Had it not been for our success in many patients we may never have pursued macular degeneration.
We discuss the discovery process in our presentations.
Prevent AMD
Failures of Dark Adaptation Testing
Drusen
Dry AMD with Vision Loss
Reducing conversion of Dry to Wet AMD
Wet AMD
Diabetic Retinopathy
Vein Occlusions
Preparing for Cataract Surgery in Eyes with AMD
Glaucoma
Retinitis Pigmentosa
Macular hole
Artery Occlusion
Macular Pucker (Epiretinal Membrane)
Floaters
Retinal Detachment
Irreversible Advance Macular Degeneration
Prevent AMD
Failures of Dark Adaptation Testing
Drusen
Dry AMD with Vision Loss
Reducing conversion of Dry to Wet AMD
Wet AMD
Diabetic Retinopathy
Vein Occlusions
Preparing for Cataract Surgery in Eyes with AMD
Glaucoma
Retinitis Pigmentosa
Macular hole
Artery Occlusion
Macular Pucker (Epiretinal Membrane)
Floaters
Retinal Detachment
Irreversible Advance Macular Degeneration
Board Certified Ophthalmology
Ph.D. in Biochemistry
Board Certified Ophthalmologist / Biomedical Engineer
PhD in Biochemistry
In the realm of vision care, particularly for those grappling with macular degeneration, every patient's story of improvement is a beacon of hope. Such is the tale of DeAn, a participant in the Macular Program, who recently shared a heartening update on her journey towards better eye health.
DeAn's experience with macular degeneration was fraught with challenges, including the presence of Drusen on her OCT scans—a common indicator of the disease's progression. Drusen are tiny yellow or white accumulations of extracellular material that build up in the macula, often signaling underlying damage that can lead to vision loss. But DeAn's story took a hopeful turn following her involvement in the Macular Program.
Under the guidance of her doctor and through the personalized treatment plan provided by the program, DeAn witnessed a remarkable transformation. "I saw my doctor yesterday," she recounts, "and the Drusen on the OCT are all gone!" This outcome is not just rare; it's a testament to the efficacy of the program's approach.
Before entering the program, DeAn required an injection every four weeks—a common treatment to slow the disease's progression and preserve vision. However, after following the Macular Program's regimen, her treatment frequency has reduced significantly to once every 16 weeks. This improvement is noteworthy, especially considering DeAn's additional eye health challenges, including cataracts and a detached retina.
The Macular Program stands apart in its approach to tackling macular degeneration. It zeroes in on hormonal decline, oxidative stress, inflammation, and disruptions in cellular processes as key factors to address. By tailoring a strategy based on a patient's medical history and biochemical profile, the program utilizes specific nutraceuticals and bio-identical hormones to optimize cellular health and gene functionality. This personalized, multi-modal strategy is what enabled DeAn to see such remarkable results.
DeAn's success story is a vivid illustration of the program's potential. It underscores the necessity of early intervention and a personalized treatment plan in reversing vision loss and halting the disease's progression. "My vision is good, in view of the fact I have had cataracts and a detached retina also," DeAn notes, highlighting the program's ability to improve quality of life despite significant eye health hurdles.
For anyone facing the uncertainties of macular degeneration, DeAn's story is a powerful reminder of the possibilities that lie in personalized, comprehensive care. It encourages those affected not to lose hope and to explore options that may offer not just a halt but a reversal in the disease's impacts.
If you or someone you know is battling macular degeneration, consider the path that DeAn took. Explore the Macular Program and its specialized approach to eye health. The journey to better vision and a higher quality of life could begin with a simple step—a step towards understanding and addressing the root causes of macular degeneration through a personalized care plan.
We invite you to learn more about the Macular Program and how it might illuminate your path to improved eye health. Join us for the Macular Masterclass, where we delve into the intricacies of the program and share more success stories like DeAn's. Let's take a step together towards preserving and enhancing your vision. Share this information with friends and family; it might just be the lifeline someone is searching for in their fight against vision loss.
Our study followed patients for 6 months. Those who improved did so generally between 2 and 6 months. Unpublished data is showing that these effects are not lost out to 2-3 years and additional improvement is possible with more time. Time and compliance with the program are the keys to continued success.
Similar to exercise and dietary practices, the favorable changes in your blood chemistry can only be sustained as long as you are taking your program.
Yes. Consistently adhering to our program has led to marked improvements for our patients. It is the combination of time and unwavering commitment to the program that paves the way for enduring success.
This decision is made by you retina doctor. However it is reasonable to ask to decrease the time between injection if the OCT scans show no remaining fluid because the HOMING Method, according to scientific literature, may decrease the creation of growth factors in the eye (for which you are receiving the injections).
The Macular Program is a form of anti-aging medicine since macular degeneration is actually called AGE RELATED macular degeneration. Fighting aging is fighting AMD. What is nice is that treating AMD with HOMING also benefits other aging symptoms which is why we want to know about your eye AND General Health.
Age-Related Macular Degeneration (AMD), whether dry or wet, is a complex condition influenced by numerous factors. Our HOMING method helps to prevent, stabilize and even reverse macular degeneration.
Geographic Atrophy is a special form of dry macular degeneration that is felt to be caused by inflammation. The HOMING method reduces inflammation. Our clinical suspicion is that GA does not worsen if a patient is on the HOMING Method. This is an important matter because new drugs now exist to fight inflammation in eyes with GA, but these drugs need to be injected into the eye. We hope the HOMING method will allow patients to avoid eye injections for GA. The smart move is to be on the HOMING method and have the GA closely followed for progression. If no progression, then you don’t need shots. It’s your call.
MacularProgram© 2023 | All Rights Reserved
All Rights Reserved 2024
Macular Program
Contact Us:
440-777-2667
Email Us: info@macularprogram.com